RUNX2 and neoplasm: These results suggest a progressive downregulation trend of RUNX1, RUNX2, and RUNX3 in COAD tumor tissues, indicating a potential role for RUNX3 and RUNX2 as tumor suppressors in COAD, in contrast to RUNX1.